104 related articles for article (PubMed ID: 1336002)
1. Management of cancer of the opposite breast following breast preservation.
Sardi A; Facundus EC; Eckholdt GJ; McKinnon WM; Skenderis BS; Bolton JS
Int Surg; 1992; 77(4):289-92. PubMed ID: 1336002
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer in situ: a retrospective review of 23 cases with a minimum of 10-year followup.
Jubelirer SJ
W V Med J; 1990 Apr; 86(4):141-4. PubMed ID: 2327090
[TBL] [Abstract][Full Text] [Related]
3. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.
Solin LJ; McCormick B; Recht A; Haffty BG; Taylor ME; Kuske RR; Bornstein BA; McNeese M; Schultz DJ; Fowble BL; Barrett W; Yeh IT; Kurtz JM; Amalric R; Fourquet A
Cancer J Sci Am; 1996; 2(3):158-65. PubMed ID: 9166516
[TBL] [Abstract][Full Text] [Related]
4. Feasibility of breast-conserving surgery for patients with breast carcinoma associated with nipple discharge.
Cabioglu N; Krishnamurthy S; Kuerer HM; Hunt KK; Singletary SE; Meric-Bernstam F; Ross MI; Feig BW; Ames FC; Babiera GV
Cancer; 2004 Aug; 101(3):508-17. PubMed ID: 15274063
[TBL] [Abstract][Full Text] [Related]
5. [The prognosis of bilateral breast carcinoma compared to unilateral breast tumor. 5- and 10-year follow-ups].
Mose S; Adamietz IA; Thilmann C; Saran F; Pahnke R; Böttcher HD
Strahlenther Onkol; 1995 Apr; 171(4):207-13. PubMed ID: 7740408
[TBL] [Abstract][Full Text] [Related]
6. Local recurrence after conservative surgery and radiation therapy for ductal carcinoma in situ: Possible importance of family history.
Hiramatsu H; Bornstein BA; Recht A; Schnitt SJ; Baum JK; Connolly JL; Duda RB; Guidi AJ; Kaelin CM; Silver EB; Harris JR
Cancer J Sci Am; 1995; 1(1):55-61. PubMed ID: 9166455
[TBL] [Abstract][Full Text] [Related]
7. Treatment of intraductal breast cancer--noncomedo type.
Griffin A; Frazee RC
Am Surg; 1993 Feb; 59(2):106-9. PubMed ID: 8386487
[TBL] [Abstract][Full Text] [Related]
8. Alternative therapy for elderly patients with breast cancer.
von Rueden DG; Sessions SC
Am Surg; 1994 Jan; 60(1):72-8. PubMed ID: 8273979
[TBL] [Abstract][Full Text] [Related]
9. Long-term cosmesis after lumpectomy and brachytherapy in the management of carcinoma of the previously irradiated breast.
Trombetta M; Julian TB; Werts DE; McWilliams W; Kim Y; Miften M; Parda D
Am J Clin Oncol; 2009 Jun; 32(3):314-8. PubMed ID: 19451803
[TBL] [Abstract][Full Text] [Related]
10. Breast conserving surgery in the management of in situ breast carcinoma.
Graham MD; Lakhani S; Gazet JC
Eur J Surg Oncol; 1991 Jun; 17(3):258-64. PubMed ID: 1646128
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer recurrences in elderly patients after lumpectomy.
Shah S; Doyle K; Lange EM; Shen P; Pennell T; Ferree C; Levine EA; Perrier ND
Am Surg; 2002 Aug; 68(8):735-9. PubMed ID: 12206612
[TBL] [Abstract][Full Text] [Related]
12. Breast carcinoma in situ in 167 women--incidence, mode of presentation, therapy and follow-up.
Ringberg A; Andersson I; Aspegren K; Linell F
Eur J Surg Oncol; 1991 Oct; 17(5):466-76. PubMed ID: 1657650
[TBL] [Abstract][Full Text] [Related]
13. Development of new cancers in patients with DCIS: the M.D. Anderson experience.
Dawood S; Broglio K; Gonzalez-Angulo AM; Kau SW; Yang W; Albarracin C; Meric F; Hortobagyi G; Theriault R
Ann Surg Oncol; 2008 Jan; 15(1):244-9. PubMed ID: 18043978
[TBL] [Abstract][Full Text] [Related]
14. Radiation therapy for ductal carcinoma in situ of the breast.
Haffty BG; Peschel RE; Papadopoulos D; Pathare P
Conn Med; 1990 Sep; 54(9):482-4. PubMed ID: 2171869
[TBL] [Abstract][Full Text] [Related]
15. [Carcinoma in situ of the breast: which treatment?].
Antonello M; Polico R; Busetto M; Schiavon S; Pizzi G
Radiol Med; 1994 Nov; 88(5):661-4. PubMed ID: 7824785
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
17. Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis.
Torrenga H; Fabry H; van der Sijp JR; van Diest PJ; Pijpers R; Meijer S
J Surg Oncol; 2004 Oct; 88(1):4-7; discussion 7-8. PubMed ID: 15384064
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcome of neoadjuvant therapy for locally advanced breast carcinoma: effective clinical downstaging allows breast preservation and predicts outstanding local control and survival.
Cance WG; Carey LA; Calvo BF; Sartor C; Sawyer L; Moore DT; Rosenman J; Ollila DW; Graham M
Ann Surg; 2002 Sep; 236(3):295-302; discussion 302-3. PubMed ID: 12192316
[TBL] [Abstract][Full Text] [Related]
19. Nipple-sparing mastectomy in association with intra operative radiotherapy (ELIOT): A new type of mastectomy for breast cancer treatment.
Petit JY; Veronesi U; Orecchia R; Luini A; Rey P; Intra M; Didier F; Martella S; Rietjens M; Garusi C; DeLorenzi F; Gatti G; Leon ME; Casadio C
Breast Cancer Res Treat; 2006 Mar; 96(1):47-51. PubMed ID: 16261402
[TBL] [Abstract][Full Text] [Related]
20. The impact of contralateral breast cancer on the outcome of breast cancer patients treated by mastectomy.
Abdalla I; Thisted RA; Heimann R
Cancer J; 2000; 6(4):266-72. PubMed ID: 11038147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
